On the world market, gold price traded at 1,938 USD/ounce. The non-farm sector added 187,000 jobs in July. However, this was lower than the previous forecast of 205,000 jobs. The not so positive economic and employment information has made investors return to buy gold to hedge against risks to capital flows. Gold prices still have room to increase. The reason is...
On the world market, spot gold on Kitco 5/8 traded at 1,942 USD/ounce. Gold price is maintaining at an important resistance level, in the context of the US labor market falling in July, inflationary pressure is still present. ANZ analysts said that the Fed's actions related to the view of adjusting interest rates in the near future could limit gold's rally. Gold...
Alembic Ltd has formed a double Bottom on weekly chart, Enter with little qty @ CMP and add on dips for the retest. Safe Buyers can wait for retest of the neckline and enter after confirmation. Please give a boost if you like the analysis and follow for more. Any suggestions or advice is humbly welcomed. Disclaimer:I am not a SEBI Registered...
NSE:SOLARA is ready to break channel pattern in upside. Financials is moderate and debt is relatively high. Key note : Always follow proper risk management to avoid losing capital from false breakouts as this is common. Caution : This is a knowledge sharing analysis, not a call. Profits are not made from following ideas, but by following Risk Management .
I was hesitant to publish this chart because the extreme upside it shows will likely be viewed as unrealistic. However, HROW recently decisively broke above its 4-year trend channel as business developments have been quite positive lately - particularly with IHEEZO. This is a rare setup where the fundamentals and technicals both align for a sharp move to the...
AMEX:LABU is about to take off, one of the sectors most affected by the reduction in earnings due to the decline in medicine sales during the pandemic. However, it shows signs of stabilization, at least a 17% and a 35% in the foreseeable future with two falling wedges. Remember cyclicals in a overload market.
Axsome Therapeutics Inc (AXSM) I have been in this spot trade since $50.77. We are now at $72.93. I have much higher targets as you can see from the chart. This is a long term trade looking to hold for 12 – 24 months however feel that something is going to happen within 6 – 12 months based on the chart. - Forming pennant on chart and RSI. Potential for...
If it holds support, it'll take off and head towards the top end of the range. Check out the crazy Call Options volume for the 8/18 $7.5 Strike Price... over 23,000 for this little unknown Pharma company. Somebody knows something... don't you think? Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of...
Olema is currently developing a "cancer" drug that suppresses the body's production of Estrogen. Now this could be useful for breast cancer treatment but the real target audience, in my opinion, is hormone replacement therapy for gender transition. I don't necessarily endorse this kind of product but given the corporate and governmental policies surrounding the...
HROW with a nice impulsive, 5-wave move off the low. HROW needs to hold the 0.618 retracement ($18.75) on this pull back, followed by a rally above the $19.95 local peak set today for further confirmation. Very bullish on the long-term prospects of this ticker.
Sunpharma broke out support trendline and retested, ready for more downsides
#SUNPHARMA... ✅▶️ Intraday as well as swing trade All levels given in charts ... IF good potential seen then we work in options also if activate then possible a huge movement Keep eye on this ... We take trade only when it activates... Possible to give good target TRADING FACTS
#APOLLOHOSP... ✅▶️ Intraday as well as swing trade All levels given in charts ... IF good potential seen then we work in options also if activate then possible a huge movement Keep eye on this ... We take trade only when it activates... Possible to give good target TRADING FACTS
MGRX a recent IPO produces a med for erectile dysfunction without FDA approval; They are basically selling a generic version of an approved medication and bypassing the patent protections and betting they will fly under the regulator radar apparatus. As might be expeted this recent nano-IPO is highlly volatile. Play with it only if you have the requisite...
WOCKPHARMA has completed a long term correction cycle and now could be a good buy with targets above 2,000 in the long term. The invalidation for this analysis remains at 135.20 (marked level).
- Big initial move right of out the gate - ~1 month consolidation - Confluence of MAs - New Momentum - High ADR - Pharma
NASDAQ:BBIO tight action. Pharma has been popping as of late - hopefully that continues. Anticipation set-up.
Tight Action on $UNCY. Massive run up on big volume and holding level.